The PE Ratio as of December 2024 (TTM) for Talis Biomedical Corporation (TLIS) is -0.06

According to Talis Biomedical Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -0.06. This represents a change of -79.13% compared to the average of -0.29 of the last 4 quarters.

Talis Biomedical Corporation (TLIS) Historical PE Ratio (quarterly & annually)

How has TLIS PE Ratio performed in the past?

The mean historical PE Ratio of Talis Biomedical Corporation over the last ten years is -1.23. The current -0.06 PE Ratio has changed 389.79% with respect to the historical average. Over the past ten years (40 quarters), TLIS's PE Ratio was at its highest in in the December 2022 quarter at 0.09. The PE Ratio was at its lowest in in the March 2020 quarter at -4.11.

Talis Biomedical Corporation (TLIS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Talis Biomedical Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Talis Biomedical Corporation (TLIS) Average PE Ratio

How has TLIS PE Ratio performed in the past?

The current PE Ratio of Talis Biomedical Corporation (TLIS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Talis Biomedical Corporation (TLIS) PE Ratio vs. Peers

How is TLIS’s PE Ratio compared to its peers?

Talis Biomedical Corporation’s PE Ratio is greater than Tivic Health Systems, Inc. (-0.22), greater than Bluejay Diagnostics, Inc. (-4.27), greater than Heart Test Laboratories, Inc. (-433.18), greater than Nuwellis, Inc. (-0.10), greater than Bone Biologics Corporation (-0.40), less than INVO Bioscience, Inc. (0), greater than Tenon Medical, Inc. (-0.11), greater than Motus GI Holdings, Inc. (-0.08), greater than Bioventus Inc. (-17.62), greater than Sight Sciences, Inc. (-3.55), greater than STRATA Skin Sciences, Inc. (-1.24), greater than NeuroPace, Inc. (-12.05), less than Vapotherm, Inc. (7.20),

Build a custom stock screener for Talis Biomedical Corporation (TLIS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Talis Biomedical Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Talis Biomedical Corporation (TLIS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Talis Biomedical Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.